Saniona - Potential for near-term royalties with Tesofensine

Redeye returns with a view on Tesofensine following the positive opinion of the drug as an obesity treatment in Mexico by the technical committee of its regulatory agency. We raise our base case to... | April 19, 2023

Related Keywords

Mexico , ,Research Powered Investment Banking ,Life Science ,Powered Investment ,Saniona Ab Publ Stock Exchange ,News ,Information ,Press Release ,Redeye ,Returns ,Ith ,View ,N ,Esofensine ,Following ,The ,Positive ,Opinion ,F ,Drug ,Us ,Obesity ,Treatment ,Y ,Echnical ,Committee ,Its ,Egulatory ,He ,Raise ,Fur ,Hase ,Ase Sanion Se0005794617 ,